- ACCESSWIRE
Relief Therapeutics Appoints David McCullough as Head of U.S. Market Access
RELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY) (" Relief "), a biopharmaceutical company seeking to provide patients therapeutic benefit from serious diseases with high unmet need, announced today the appointment of David McCullough as Senior Director and Head of U.S. Market Access, effective August 22 nd . In this newly created position, reporting to Anthony Kim, Senior Vice President and Head of U.S.
- PR Newswire
Aker ASA: Half-Year and Second Quarter Results 2022 - Net Asset Value increase of NOK 2.2 billion in the first half of the year
The Net Asset Value ("NAV") of Aker ASA and holding companies ("Aker") increased with NOK 2.2 billion, or 3.1 per cent, to NOK 72.0 billion in the first half of the year, net of dividends paid in the period of NOK 1.1 billion. For the second quarter of 2022, the NAV decreased with NOK 2.8 billion, or 3.7 per cent, compared to the first quarter of 2022, including NOK 1.1 billion in dividends paid.
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
